Xtl Biopharmaceuticals (XTLB) Change in Account Payables (2009 - 2016)
Xtl Biopharmaceuticals (XTLB) posted quarterly Change in Account Payables of -$40000.0 for Q2 2016, down 500.0% year-on-year from $10000.0 in Q3 2015, and up 45.95% on a QoQ basis from -$74000.0 in Q4 2015.
Xtl Biopharmaceuticals (XTLB) Change in Account Payables (2009 - 2016) Analysis & Trends
Xtl Biopharmaceuticals (XTLB) has reported Change in Account Payables for 6 consecutive years, with -$40000.0 the latest figure, recorded in Q2 2016.
- Quarterly Change in Account Payables fell 500.0% year-over-year to -$40000.0 in Q2 2016, while the trailing twelve-month figure through Jun 2016 was -$64000.0 (up 83.16% YoY) and the FY2025 annual result came in at -$187000.0, down 189.9% from the prior year.
- Change in Account Payables advanced to -$40000.0 in Q2 2016 per XTLB's latest filing, from -$74000.0 in the prior quarter.
- Over the last five years, Change in Account Payables for XTLB reached as high as $322000.0 in Q1 2014 and fell as low as -$164000.0 in Q4 2014.
- A 4-year average of -$36166.7 and a median of -$72500.0 in 2013 frame the typical range for Change in Account Payables.
- The largest YoY upside for Change in Account Payables was 351.56% in 2014 against a maximum downside of 1540.0% in 2014.
- Year by year, Change in Account Payables stood at -$10000.0 in 2013, then tumbled by 1540.0% to -$164000.0 in 2014, then soared by 54.88% to -$74000.0 in 2015, then soared by 45.95% to -$40000.0 in 2016.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$40000.0, -$74000.0, and $40000.0 for Q2 2016, Q4 2015, and Q3 2015 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | -40,000.00 |
| Jun 30, 2016 | -40,000.00 |
| Dec 31, 2015 | -74,000.00 |
| Dec 31, 2015 | -74,000.00 |
| Sep 30, 2015 | 40,000.00 |
| Sep 30, 2015 | 40,000.00 |
| Jun 30, 2015 | 10,000.00 |
| Jun 30, 2015 | 10,000.00 |
| Dec 31, 2014 | -164,000.00 |
| Dec 31, 2014 | -164,000.00 |
| Sep 30, 2014 | -123,000.00 |
| Sep 30, 2014 | -123,000.00 |
| Jun 30, 2014 | -103,000.00 |
| Jun 30, 2014 | -103,000.00 |
| Mar 31, 2014 | 322,000.00 |
| Mar 31, 2014 | 322,000.00 |
| Dec 31, 2013 | -10,000.00 |
| Dec 31, 2013 | -10,000.00 |
| Sep 30, 2013 | -93,000.00 |
| Sep 30, 2013 | -93,000.00 |